Literature DB >> 32576072

Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis.

Yin Zheng1, Zihui Tang2, Li You1, Yuanhao Wu1, Junfeng Liu1, Jun Xue1.   

Abstract

Background: Hospitalization is a significant outcome measurement for maintenance hemodialysis pantients. Trimethylamine-N-oxide (TMAO), created by gut microflora from dietary l-carnitine and choline, cleared by the kidney, has been implicated in the causation of cardiovascular diseases in patients with chronic kidney disease. However, whether it associates with hospitalization risk for these patients is unclear.
Methods: In this study, 69 patients undergoing outpatient dialysis were enrolled. Enzyme-linked immunosorbent assay was used to quantitate the baseline plasma TMAO levels in patients. The patients were divided into a high TMAO level group (TMAO ≥ 15 μmol/L) and a low TMAO level group (TMAO < 15 μmol/L). During the 1-year follow-up, 1-year dialysis-related data and all-cause hospitalization events were recorded.
Results: The incidence of hospitalization events was significantly higher in the high TMAO level group than in the low TMAO level group (91 per 100 patient-year vs. 32 per 100 patient-year). The Kaplain-Meier survaial analysis showed that the incidence of hospitalization events in the high TMAO level group was significantly higher than that in the low TMAO level group (log-rank p = 0.0004). After adjustment age, sex, CK-MB and albumin, the results of multivariate Cox proportional hazard analysis showed that high TMAO level was an independent risk factor for hospitalization in maintenance hemodialysis patients.
Conclusion: TMAO is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis. It may be a new therapeutic target for improving the outcomes of these patients.

Entities:  

Keywords:  Chronic kidney disease; hemodialysis; hospitalization events; trimethylamine; trimethylamine-N-oxide

Year:  2020        PMID: 32576072      PMCID: PMC7946050          DOI: 10.1080/0886022X.2020.1781170

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  29 in total

1.  Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD.

Authors:  W H Wilson Tang
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121

2.  Chronic kidney disease in the developing world.

Authors:  Rashad S Barsoum
Journal:  N Engl J Med       Date:  2006-03-09       Impact factor: 91.245

3.  A Gut Feeling about Thrombosis.

Authors:  Herbert Tilg
Journal:  N Engl J Med       Date:  2016-06-23       Impact factor: 91.245

4.  Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.

Authors:  George A Kaysen; Kirsten L Johansen; Glenn M Chertow; Lorien S Dalrymple; John Kornak; Barbara Grimes; Tjien Dwyer; Alexander W Chassy; Oliver Fiehn
Journal:  J Ren Nutr       Date:  2015-03-19       Impact factor: 3.655

5.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

6.  Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.

Authors:  Manuel Ottiger; Manuela Nickler; Christian Steuer; Jonas Odermatt; Andreas Huber; Mirjam Christ-Crain; Christoph Henzen; Claus Hoess; Robert Thomann; Werner Zimmerli; Beat Mueller; Philipp Schuetz
Journal:  Eur J Intern Med       Date:  2016-08-24       Impact factor: 4.487

7.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

Authors:  Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121

8.  Hospitalization among United States dialysis patients: hemodialysis versus peritoneal dialysis.

Authors:  G Habach; W E Bloembergen; E A Mauger; R A Wolfe; F K Port
Journal:  J Am Soc Nephrol       Date:  1995-05       Impact factor: 10.121

9.  Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus.

Authors:  Peiyun Li; Chunrong Zhong; Shuzhen Li; Taoping Sun; Hao Huang; Xi Chen; Yalun Zhu; Xiaoli Hu; Xiaobo Peng; Xu Zhang; Wei Bao; Zhilei Shan; Jinquan Cheng; Frank B Hu; Nianhong Yang; Liegang Liu
Journal:  Am J Clin Nutr       Date:  2018-09-01       Impact factor: 7.045

10.  Endoscopic alterations in a cohort of hemodialysis patients: a cross-sectional study.

Authors:  Mr Bacci; Ft Russo; Gd Carvalho; Ez Chehter; Vc Jordao; Fl Fonseca
Journal:  Int J Gen Med       Date:  2014-09-16
View more
  6 in total

1.  Analysis of inflammatory factor levels in serum and risk factors in patients with chronic renal failure undergoing maintenance hemodialysis.

Authors:  Min Zhou; Yuan Du; Yanping Wu; Ping Zhang; Peng Liu; Jiarui Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 2.  Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.

Authors:  Doudou Li; Ying Lu; Shuai Yuan; Xiaxia Cai; Yuan He; Jie Chen; Qiong Wu; Di He; Aiping Fang; Yacong Bo; Peige Song; Debby Bogaert; Kostas Tsilidis; Susanna C Larsson; Huanling Yu; Huilian Zhu; Evropi Theodoratou; Yimin Zhu; Xue Li
Journal:  Am J Clin Nutr       Date:  2022-07-06       Impact factor: 8.472

3.  The Fibrotic Effects of TMAO on Human Renal Fibroblasts Is Mediated by NLRP3, Caspase-1 and the PERK/Akt/mTOR Pathway.

Authors:  Stefania Kapetanaki; Ashok Kumar Kumawat; Katarina Persson; Isak Demirel
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

4.  Association between nutritional, inflammatory and oxidative status (NIOS) and risk of adverse outcomes in patients on haemodialysis (HD): the NIOS-HD prospective cohort study protocol.

Authors:  Sahar Foshati; Gholamreza Askari; Mohammad Bagherniya; Mojgan Mortazavi; Firouzeh Moeinzadeh; Shahram Taheri; Zahra Heidari; Mohammad Hossein Rouhani
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

5.  TMAO Suppresses Megalin Expression and Albumin Uptake in Human Proximal Tubular Cells Via PI3K and ERK Signaling.

Authors:  Stefania Kapetanaki; Ashok Kumar Kumawat; Katarina Persson; Isak Demirel
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

6.  Association of trimethylamine N-Oxide with cardiovascular and all-cause mortality in hemodialysis patients.

Authors:  Pan Zhang; Jian-Zhou Zou; Jun Chen; Xiao Tan; Fang-Fang Xiang; Bo Shen; Jia-Chang Hu; Jia-Lin Wang; Ya-Qiong Wang; Jin-Bo Yu; Yu-Xin Nie; Xiao-Hong Chen; Jia-Wei Yu; Zhen Zhang; Wen-Lv Lv; Ye-Qing Xie; Xue-Sen Cao; Xiao-Qiang Ding
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.